Customizable Cell Free DNA Precise Non Invasive Prenatal Testing NIPT Tube
| Color | Purple |
| Feature | Custom manufacturing available |
| Application | Non Invasive Prenatal Testing (NIPT) |
| Material | Glass and plastic |
| Advantage | Sterile and safe, compatible with standard equipment |
Orsin Medical Technology's Cell-Free DNA (cfDNA) Detection System revolutionizes disease diagnosis and monitoring through cutting-edge liquid biopsy technology. Our solution delivers highly sensitive, non-invasive, and real-time genomic analysis for early cancer screening, prenatal testing, transplant monitoring, and more.
- Ultra-Sensitive Detection - Powered by NGS and proprietary bioinformatics, our platform detects trace cfDNA mutations with >99% accuracy, enabling early disease identification.
- Minimally Invasive - A simple blood draw replaces risky tissue biopsies, ensuring patient safety and comfort.
- Multi-Application Flexibility - Covers oncology (early cancer screening, MRD monitoring), NIPT (fetal aneuploidy detection), and transplant rejection tracking.
- Rapid & Scalable - High-throughput workflow delivers fast, reliable results, ideal for clinical and research use.
- AI-Enhanced Analysis - Advanced algorithms improve mutation calling, reducing false positives/negatives.
| Parameter | Specification | Significance |
|---|---|---|
| Sample Input Volume | 0.5-4 mL plasma/serum | Optimized for low-abundance cfDNA in clinical samples |
| Extraction Time | ≤60 minutes | Rapid workflow for high-throughput labs |
| DNA Yield | 70-90% recovery (spiked-in controls) | High efficiency for short fragments (50-300 bp) |
| Purity (A260/A280) | 1.7-2.0 | Ideal for downstream NGS/PCR without protein/RNA contamination |
| Fragment Range | 50-300 bp (optimized for ≤166 bp) | Captures tumor/placental-derived cfDNA |
| Inhibitor Removal | Effective against heparin, hemoglobin, etc. | Ensures PCR/NGS compatibility |
| Automation Compatibility | Compatible with major liquid handlers | Scalable for clinical/large-scale research |
| Storage Conditions | 2-8°C (stable for 24 months) | Long shelf life with minimal batch variability |
| Cap Color | Additive | Mixing | Inversion Count | Clinical Applications |
|---|---|---|---|---|
| Red | None/Clot activator | 5× | 5-6 | Serum chemistry, Immunology |
| Purple | K2/K3 EDTA | 8-10× | 8-10 | Hematology (CBC, Blood Smear) |
| Green | Lithium Heparin | 8-10× | 8-10 | Plasma chemistry, STAT tests |
| Gray | NaF/K Oxalate | 8-10× | 8-10 | Glucose tolerance, Alcohol tests |
| Blue | Sodium Citrate | 3-4× | 3-4 | Coagulation tests (PT, APTT) |
Blood tests for routine diagnostics (CBC, biochemistry, coagulation) in outpatient/inpatient settings.
- Accurate Volume Control (±5% tolerance) ensures consistent results and reduces retesting rates
- Multiple additives (EDTA, heparin, sodium citrate) tailored for diverse testing requirements
- Compatibility with automated analyzers and seamless integration with hospital LIS/HIS systems
Rapid analysis of blood gases, electrolytes, and cardiac markers in urgent care.
- DHA (Dual Hemostasis Activator) Technology accelerates blood separation, reducing preprocessing time (
- Gray-top tubes prevent glucose degradation for accurate emergency glucose testing
Genomics (DNA/RNA extraction), proteomics, and drug metabolism research.
- Sterile, non-pyrogenic design eliminates exogenous contamination
- Customization options available for high-sensitivity assays
- Clinically Validated - Trusted by leading hospitals and labs
- Cost-Effective - Reduces unnecessary invasive procedures and long hospital stays
- Future-Ready - Continuously optimized for emerging biomarkers
Orsin Medical Technology empowers precision medicine with smarter, safer, and faster cfDNA diagnostics. Early detection. Better outcomes.
Get in Touch
Have questions about our products or want to discuss a custom order? Our team is ready to help you.